(19)
(11) EP 2 480 655 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
10.08.2016 Bulletin 2016/32

(45) Mention of the grant of the patent:
27.01.2016 Bulletin 2016/04

(21) Application number: 10779041.2

(22) Date of filing: 24.09.2010
(51) International Patent Classification (IPC): 
C12N 5/071(2010.01)
C12N 5/00(2006.01)
(86) International application number:
PCT/IB2010/054303
(87) International publication number:
WO 2011/036637 (31.03.2011 Gazette 2011/13)

(54)

CELL CULTURE MEDIUM

ZELLKULTURMEDIUM

MILIEU DE CULTURE DE CELLULES


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(30) Priority: 25.09.2009 HU 0900603

(43) Date of publication of application:
01.08.2012 Bulletin 2012/31

(73) Proprietor: Biomarker Ltd
2100 Gödöllö (HU)

(72) Inventors:
  • SKRIBEK, Henriette
    H-2100 Gödöllö (HU)
  • SZÉKELY, László
    S-13936 Värmdö (SE)

(74) Representative: Lengyel, Zsolt 
Danubia Patent & Law Office LLC Bajcsy-Zsilinszky út 16
1051 Budapest
1051 Budapest (HU)


(56) References cited: : 
WO-A1-02/102395
WO-A1-2008/077638
   
  • HOCHART HELENE ET AL: "Concentration-dependent roles for heparin in modifying lipopolysaccharide-induced activation of mononuclear cells in whole blood.", THROMBOSIS AND HAEMOSTASIS MAR 2008 LNKD- PUBMED:18327406, vol. 99, no. 3, March 2008 (2008-03), pages 570-575, XP9145928, ISSN: 0340-6245
  • GASZLING V L W ET AL: "Platelet-rich Plasma and Platelet-rich fibrin in human cell culture", ORAL SURGERY, ORAL MEDICINE, ORAL PATHOLOGY, ORAL RADIOLOGY AND ENDODONTICS, MOSBY-YEAR BOOK, ST. LOUIS, MO, US, vol. 108, no. 1, 1 July 2009 (2009-07-01), pages 48-55, XP026434161, ISSN: 1079-2104 [retrieved on 2009-05-17]
  • AROSA FAPEREIRA CFFONSECA AM: "Red blood cells as modulators of T cell growth and survival", CURR PHARM DES, vol. 10, 20 April 2001 (2001-04-20), pages 191-201, XP9145923,
  • FONSECA ANA MAFALDA ET AL: "Red blood cells upregulate cytoprotective proteins and the labile iron pool in dividing human T cells despite a reduction in oxidative stress", FREE RADICAL BIOLOGY AND MEDICINE, ELSEVIER SCIENCE, US, vol. 35, no. 11, 1 December 2003 (2003-12-01), pages 1404-1416, XP009145922, ISSN: 0891-5849
  • ALSOUSOU J ET AL: "The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature.", THE JOURNAL OF BONE AND JOINT SURGERY. BRITISH VOLUME AUG 2009 LNKD- PUBMED:19651823, vol. 91, no. 8, August 2009 (2009-08), pages 987-996, XP9145933, ISSN: 0301-620X
  • VICENTE MIRABET ET AL: "Human platelet lysate enhances the proliferative activity of cultured human fibroblast-like cells from different tissues", CELL AND TISSUE BANKING, KLUWER ACADEMIC PUBLISHERS, DO, vol. 9, no. 1, 20 June 2007 (2007-06-20), pages 1-10, XP019570750, ISSN: 1573-6814
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).